drugset / Trial / NCT07308184
Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase 3 Bridge study is designed to evaluate the efficacy and safety of IN-B00009 Injection in Patients with T2DM Inadequately Controlled by Diet and Exercise Alone
Timeline
- Start
- 2025-12
- Primary completion
- 2027-08
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IN-B00009 | Unknown | 1.2 mg | — |